Compare PRU & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRU | MDLN |
|---|---|---|
| Founded | 1875 | 1966 |
| Country | United States | United States |
| Employees | 36824 | 45000 |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.0B | 34.1B |
| IPO Year | N/A | N/A |
| Metric | PRU | MDLN |
|---|---|---|
| Price | $97.66 | $44.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 23 |
| Target Price | ★ $114.00 | $50.48 |
| AVG Volume (30 Days) | 1.9M | ★ 7.1M |
| Earning Date | 04-29-2026 | 02-25-2026 |
| Dividend Yield | ★ 5.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.83 |
| Revenue Next Year | $3.10 | $7.68 |
| P/E Ratio | ★ $10.44 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.38 | $38.50 |
| 52 Week High | $119.76 | $50.88 |
| Indicator | PRU | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 52.79 |
| Support Level | $91.89 | $43.04 |
| Resistance Level | $105.61 | $44.11 |
| Average True Range (ATR) | 2.08 | 1.44 |
| MACD | 0.89 | 0.32 |
| Stochastic Oscillator | 76.48 | 72.45 |
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.